Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma

Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma

Cutaneous Melanoma (CM) is an aggressive cancer whose incidence is increasing worldwide. However, the knowledge of its biology and genes driving cell growth and survival allowed to develop new drugs that have improved PFS and OS of advanced disease. Both BRAF targeting agents and immune checkpoint i...

Full description

Bibliographic Details
Main Authors: Riccardo Marconcini, Gaetano Pezzicoli, Luigia Stefania Stucci, Maria Chiara Sergi, Lucia Lospalluti, Camillo Porta, Marco Tucci
Format: Article
Language:English
Published: Taylor & Francis Group 2022-05-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
melanoma
icis
targeted therapy
sequencing
anti-pd1
Online Access:http://dx.doi.org/10.1080/21645515.2021.1980315

Internet

http://dx.doi.org/10.1080/21645515.2021.1980315

Similar Items